These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7300762)
21. Danger of withdrawal of vasodilator therapy in patients with chronic heart-failure. Hanley SP; Cowley A; Hampton JR Lancet; 1980 Apr; 1(8171):735-6. PubMed ID: 6103157 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography. Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789 [TBL] [Abstract][Full Text] [Related]
23. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)]. Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350 [No Abstract] [Full Text] [Related]
24. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin. Sharpe DN; Coxon R Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361 [TBL] [Abstract][Full Text] [Related]
25. Heart rate response to oral prazosin in patients with chronic congestive heart failure. Elkayam U Am J Cardiol; 1980 Oct; 46(4):704. PubMed ID: 7416031 [No Abstract] [Full Text] [Related]
26. Prazosin in the treatment of severe chronic congestive cardiac failure. Hockings BE; Cope GD; Clarke GM; Taylor RR Aust N Z J Med; 1980 Aug; 10(4):420-5. PubMed ID: 6932833 [TBL] [Abstract][Full Text] [Related]
27. [Effect of prazosin in therapy-resistant chronic cardiac failure (author's transl)]. Lemke R; Trompler A; Kaltenbach M; Bussmann WD Dtsch Med Wochenschr; 1979 Dec; 104(50):1769-73. PubMed ID: 510213 [TBL] [Abstract][Full Text] [Related]
28. Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin. Packer M; Meller J; Gorlin R; Herman MV Am J Cardiol; 1979 Aug; 44(2):310-7. PubMed ID: 463769 [TBL] [Abstract][Full Text] [Related]
29. Prazosin in the therapy of uncontrolled hypertension. Lubbe WF S Afr Med J; 1977 Nov; 52(23):913-8. PubMed ID: 339373 [TBL] [Abstract][Full Text] [Related]
30. [Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure]. Kersting F; Samosny G; Kasper W; Schuster HP Med Welt; 1981 Jun; 32(26):1040-5. PubMed ID: 6114383 [No Abstract] [Full Text] [Related]
31. Vasodilator therapy--a physiologic approach to the treatment of heart failure. Braunwald E N Engl J Med; 1977 Aug; 297(6):331-3. PubMed ID: 876316 [No Abstract] [Full Text] [Related]
32. Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. Laslett LJ; DeMaria AN; Amsterdam EA; Mason DT Arch Intern Med; 1978 May; 138(5):819-20. PubMed ID: 646547 [TBL] [Abstract][Full Text] [Related]